Skip to main content
ZERIA PHARMCEUTICAL CO., LTD. logo

ZERIA PHARMCEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 4559 ISIN · JP3428850006 T Manufacturing
Open in API
Filings indexed 64 across all filing types
Latest filing 2022-06-29 Governance Information
Country JP Japan
Listing T 4559

About ZERIA PHARMCEUTICAL CO., LTD.

https://www.zeria.co.jp/english/

Zeria Pharmaceutical Co., Ltd. is a comprehensive healthcare company established in 1955. The company's operations are structured around two primary business segments: Ethical Pharmaceuticals and Consumer Healthcare. Its activities include the research, development, manufacturing, and distribution of a diverse range of products, including prescription medications, over-the-counter drugs, and other health-related goods. Zeria focuses on developing innovative pharmaceutical products to contribute to the health of people globally.

Recent filings

Filing Released Lang Actions
内部統制報告書－第68期(令和3年4月1日－令和4年3月31日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act (金融商品取引法). This is a specific regulatory requirement in Japan for companies to report on the effectiveness of their internal controls over financial reporting. Since it is a standalone regulatory filing regarding internal control systems and does not fit into the other specific categories like 10-K or IR, it is classified as a Regulatory Filing (RNS).
2022-06-29 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の４の２第１項' (Article 24-4-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 2022
2022-06-29 Japanese
有価証券報告書－第68期(令和3年4月1日－令和4年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of the US 10-K annual report. It contains the official filing cover page, fiscal year information (2021-04-01 to 2022-03-31), and extensive XBRL-like metadata tags indicating it is a comprehensive annual financial disclosure. FY 2022
2022-06-29 Japanese
変更報告書
Major Shareholding Notification Classification · 100% confidence The document is a '大量保有報告書' (Large Shareholding Report), which is a mandatory regulatory filing in Japan under the Financial Instruments and Exchange Act. It details the change in shareholding percentage by Zeria Pharmaceutical Co., Ltd. in Aska Pharmaceutical Holdings Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-06-09 Japanese
四半期報告書－第68期第3四半期(令和3年10月1日－令和3年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Zeria Pharmaceutical Co., Ltd., covering the third quarter of the 68th fiscal year (period ending December 31, 2021). It contains detailed financial statements, including the consolidated balance sheet, income statement, and comprehensive income statement, as well as management analysis and notes. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. 9M 2022
2022-02-04 Japanese
四半期報告書－第68期第2四半期(令和3年7月1日－令和3年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the regulatory reference (Financial Instruments and Exchange Act). It contains detailed financial statements, management analysis, and audit review information for the second quarter of the 68th fiscal period. This fits the definition of an Interim/Quarterly Report (IR). H1 2022
2021-11-08 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.